PSMD1 and COVID-19: Notably, it has been observed that T-cells had higher reactivity against the S1 antigen of HCoV-OC43 and HCoV-NL63, and against the S2 antigen of HCoV-OC43 and HCoV-229E in COVID-19 survivors (9).